Probiotics in health and disease: fooling Mother Nature?
- 362 Downloads
Probiotics are ubiquitous, consumption by the general public is common, and the dogma remains that they are beneficial for general and gut health. However, evolving evidence suggests a potentially “harmful” impact of many commercially available probiotics. There is also significant variability in formulations that leads to a lack of a universally acceptable definition of probiotics. In this perspective, we review the flaws with definition, relevant observational and randomized studies that showed both positive and negative impacts on health and disease, unbiased interpretation of key trials, emerging evidence from microbiome and immuno-oncological studies, and impact on systemic immunity. We propose that caution be exercised prior to endorsements of their illness-directed consumption and rampant general usage. As a deeper understanding of the human microbiome accrues and our ability to manipulate this complex ecosystem improves, the probiotic of tomorrow might be the precision tool that deals with diseases on a broad front. Gut microbiome, akin to fingerprints, is indigenous to an individual and ‘one size fits all’ prescription strategy should be discouraged until a more universally acceptable ‘favorable taxa’ or a ‘personalized probiotic,’ to complement an individual’s native microbiota, gets fashioned.
KeywordsCommercial probiotics Gut microbiome Dysbiosis
MBA conceived of the idea, performed the literature search, wrote the manuscript, and drew the table. CJK co-wrote the manuscript. Both authors performed a critical revision of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare no potential conflict of interest.
- 1.Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Rep. 2015;79:1–16.Google Scholar
- 4.Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators Inflamm. 2014;2014:348959.PubMedPubMedCentralGoogle Scholar
- 9.Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;12:CD004827.Google Scholar
- 17.Allen SJ, Wareham K, Wang D, et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess. 2013;17(57):1–140.PubMedPubMedCentralGoogle Scholar
- 31.Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14.Google Scholar
- 41.Gopalakrishnan V, Spencer C, McQuade J, et al. The gut microbiome of metastatic melanoma patients initiating systemic therapy is influenced by host factors including diet, probiotic and antibiotic use. P505. The Annual Meeting of the Society for Immunotherapy of Cancer. November 7–11, 2018. Washington, DC.Google Scholar
- 42.“Global Probiotics Market Will Reach USD 65.87 Billion by 2024: Zion Market Research.” “GlobeNewswire”, 21 June 2018, globenewswire.com/news-release/2018/06/21/1527822/0/en/Global-Probiotics-Market-Will-Reach-USD-65-87-Billion-by-2024-Zion-Market-Research.html. Accessed 7 Mar 2019.
- 43.“Global Antihypertensive Drugs Market US$ 23.1 Billion by 2023.” Healthcare Market Research and Consulting Services, IHealthcareAnalyst, Inc, 28 Sept. 2018, www.ihealthcareanalyst.com/global-antihypertensive-drugs-market/. Accessed 7 Mar 2019.
- 45.Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;2:CD006895.Google Scholar
- 46.Barrett HL, Dekker Nitert M, Conwell LS, Callaway LK. Probiotics for preventing gestational diabetes. Cochrane Database Syst Rev. 2014;2:CD009951.Google Scholar